jwowsworld

jwowsworld Intech Investment Management LLC Takes $753,000 Position in Omnicell, Inc. (NASDAQ:OMCL)Txnm energy director Norman Becker sells $111,366 in stock

After battling advanced prostate cancer for a decade, Jim Larson said his doctor recommended he try a new treatment. Pluvicto is the brand name for a treatment that kills cancer cells with the radioactive isotope lutetium-177. Pharmaceutical company Novartis offers the treatment at $27,000 per dose — putting the average five-dose treatment at $135,000. "I was all ready to go. We were excited," he said. "But there's no money now to pay for the drug from the government. And without that, it's not going to go anywhere." Earlier this month, the pan-Canadian Pharmaceutical Alliance (pCPA) — which negotiates drug prices for provincial, territorial and federal public health plans — ended talks with Novartis, even though the Canadian Agency for Drugs and Technologies in Health recommends provinces cover Pluvicto treatments. Now, hundreds of eligible patients will need to pay thousands of dollars to access the treatment. Larson is calling for pCPA and Novartis to get back to the table and for the federal government to cover Pluvicto for eligible patients. "If this doesn't happen within the next few months, we're going to start to lose people," he said. "People are going to die." According to the B.C. Cancer Agency, about 3,500 British Columbians are diagnosed with prostate cancer each year, and in 2021 alone, 705 people died from the disease. Pluvicto is one of the few lutetium-177 cancer treatments approved in Canada. The compound is injected intravenously and circulates around a patient's body until it encounters a prostate cancer cell. Then, it attaches itself to the cell before it disintegrates, emitting a beta particle which shreds DNA in the nucleus of the cancer cell — usually killing it. Dr. Philip Cohen, a Metro Vancouver-based nuclear medicine researcher, said the treatment sometimes targets salivary glands and tear ducts, leaving patients with a dry mouth. He said patients often show less severe side effects compared to chemotherapy, which can leave patients feeling nauseous and tired. He said Pluvicto is one of about 20 new compounds reaching Canada's drug approval process that aim to treat cancer in a similar way. Mina Bechai, the CEO and Founder of Initio Medical, a private facility in Burnaby, B.C., where patients can access the treatment, said treatments like the lutetium-177 injection are promising. "They have been very effective, but it all depends on the intervention time," he said. "If you get into it too late, then you won't really be able to help those patients." He said the treatment could help hundreds of cancer survivors, but the high cost prevents many patients from accessing Pluvicto. "Patients have to self-fund their own treatment. That's the sad part," he said. "We've got to do whatever we have to do to make options available." Health Canada first approved Pluvicto in 2022. In B.C., cancer treatments are covered through the B.C. Cancer Agency, which has no compassionate supply of Pluvicto. A spokesperson for B.C. Cancer said after negotiations between the pCPA and Novartis collapsed, British Columbians would have to access the drug through third-party insurance or by paying for the treatment at a private facility. Dominic Tan, acting pCPA CEO, said the alliance ended negotiations over the Pluvicto when it decided Novartis's best offer for the cost of the drug was higher than the pCPA assessed it was worth. "Despite a significant shift from the pCPA to compromise on price, during the many months of negotiation, the price gap for the drug remains too wide," Tan said in an emailed statement. "The pCPA has a responsibility to ensure that the price it negotiates for a drug is consistent with the evidence of its clinical benefit to patients and sustainable for the health system as a whole." Tan said the alliance was disappointed by the result of the negotiation and recognizes the decision may also disappoint the patients, families and caregivers who were awaiting its results. He said the pCPA is willing to head back to negotiations. Meanwhile, a spokesperson for Novartis, said the company was also disappointed by the decision. "We have heard from physicians, physician associations, and patient groups ... who need options that will allow them not only to live longer but also preserve quality of life so they can continue to celebrate important milestones with loved ones," a spokesperson said in an email. Novartis said the average treatment is 4.54 doses. Each dose of Pluvicto must be made to order and requires a highly specialized manufacturing and distribution process to ensure each patient gets the right dose at the right time, which factors into the cost of the treatment, Novartis said. It said it is prepared to pursue all available options to ensure eligible patients can access the treatment. But that's not enough for Larson. He's calling for both sides to get back to the table and come to an agreement. "Nobody wins when you walk away. Everybody loses. Get back to that table, Negotiate until you have a deal."

ISLAMABAD, (UrduPoint / Pakistan Point News - 30th Nov, 2024) The ’s Parliamentary Caucus (WPC) will host a two-day workshop to promote ’s rights and foster an inclusive political environment, in collaboration with the ( ). The ’s Parliamentary Caucus (WPC) of ’s 16th , under the leadership of Secretary WPC Dr. Shahida Rehmani, will host the “Thought Leadership Workshop” on ( 1st) and the “Digital Workshop” on Monday ( 2nd). These workshops are a key component of the 16 Days of Activism Against Gender-Based Violence, a global call to action for the protection and empowerment of . They will focus on addressing critical issues such as ending gender-based violence, ensuring ’s physical, social, legal, and online safety, and combating forms of harassment. The workshops are designed to facilitate a powerful dialogue and equip participants with the skills, knowledge & tools needed for identifying, sensitising and tackling women-related issues through informed legislation and promoting and upholding digital . Secretary of the 's Parliamentary Caucus and a Member of the , Dr. Shahida Rehmani will deliver keynote addresses, outlining the core objectives of the workshops. She will emphasize the importance of empowering Members of the to ensure robust participation in 's General Elections. Additionally, Dr. Shahida Rehmani will underscore the need for ethical parliamentary practices, enhanced digital literacy to counter technology-facilitated gender-based violence, and crucially, the development of skills in managing and narratives to tackle the growing menace of misinformation, fake , and propaganda. In addition, a panel of esteemed speakers, including renowned journalists, veteran personalities, experts, and key societal figures, will engage in thought-provoking discussions and interactive sessions to provide valuable insights on these pressing issues. This collaborative effort is a significant step forward in empowering , particularly within the political sphere, to create a safer, more equitable society for .

CHADDS FORD, PA — MOBILion Systems, Inc. recently announced the formation of a Proteomics Advisory Board, bringing together leading experts to guide the advancement of its cutting-edge technology in complex sample analysis. This initiative underscores the company’s commitment to pushing the boundaries of proteomics research and solutions. The advisory board’s primary focus will be on supporting MOBILion as it develops its next-generation technology, which aims to address some of the biggest challenges in the analysis of complex biological samples. The company’s innovative approach, powered by its proprietary operating mode known as PAMAF, promises faster and more sensitive results—capabilities that could redefine the field of proteomics. “We are honored to be working with such visionary leaders whose groundbreaking contributions have shaped the proteomics landscape,” said Daniel DeBord, Ph.D., Chief Technology Officer of MOBILion Systems. “The expertise of this board will help ensure we develop solutions that meet the most pressing challenges researchers face, advancing the future of proteomics research and innovation.” The Proteomics Advisory Board consists of seven prominent figures from academia and industry, each with extensive experience in proteomics and related fields. The current members include: Steven Carr, Ph.D. – Senior Director of Proteomics at the Broad Institute, recognized for his development of proteomics methods in biomedical applications. Ashok Dongre, Ph.D. – Senior Director of Proteomics at Bristol Myers Squibb, with over 25 years of experience in pharmaceutical research. Alexey Nesvizhskii, Ph.D. – Professor of Bioinformatics at the University of Michigan, known for his work in mass spectrometry-based proteomics. Ben Orsburn, Ph.D. – Proteomics and mass spectrometry researcher with expertise in developing novel technologies for Johns Hopkins University and other institutions. Birgit Schilling, Ph.D. – Director of the Mass Spectrometry Core at the Buck Institute, specializing in data-driven proteomics. Nikolai Slavov, Ph.D. – Bioengineering professor at Northeastern University and a pioneer in single-cell proteomics. John R. Yates III, Ph.D. – Esteemed professor at The Scripps Research Institute and a leading figure in proteomics technology innovation. MOBILion notes that the board may evolve as new needs arise for expertise in specific applications or workflows. By leveraging the knowledge and experience of these distinguished scientists, MOBILion aims to refine and expand the practical applications of its technology, ultimately driving meaningful advances in biology, medicine, and beyond. For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN .

I Found the Best Black Friday Laptop Deals: Get a MacBook Air for $200 OffBOULDER, Colo. (AP) — Nyla Harris had 14 points and Jayda Curry scored 10 of her 14 points in the fourth quarter to help No. 24 Louisville get past Colorado 79-71 on Saturday. The Cardinals led 56-55 after three quarters before pulling away in the fourth by scoring 16 unanswered points, capped by a fast-break layup by Curry, before Colorado made its first field goal of the frame with 2:48 left. Colorado scored the next six points to get within single digits at 72-63, but freshman Tajianna Roberts banked in a jumper in the lane at the other end. Izela Arenas sealed it on two free throws with 24.9 seconds left for a nine-point lead. Roberts finished with 13 and Arenas had 11 for Louisville (5-2). Frida Formann scored 25 points for Colorado (6-2). Jade Masogayo added 12 points, Nyamer Diew scored 10 and Kindyll Wetta matched her career-high with 10 assists. Formann went on a personal 8-0 run to give Colorado a 43-37 lead with 7:38 left in the third. She reached 20 points during the run, while no other player had scored in double figures. Louisville plays No. 8 Oklahoma on Wednesday in the SEC/ACC Challenge. Colorado continues a five-game homestand against Tennesse Tech on Tuesday. ___ Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP women’s college basketball: https://apnews.com/hub/ap-top-25-womens-college-basketball-poll and https://apnews.com/hub/womens-college-basketball

LOS ANGELES--(BUSINESS WIRE)--Nov 25, 2024-- Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future,” “FF,” or “the Company”), a California-based global shared intelligent electric mobility ecosystem company, announced today that it plans to change its Nasdaq ticker symbol from “FFIE” to “FFAI” in early 2025. This change aligns with the Company’s continued focus on its AI strategy that includes its new FX brand strategy. Surveys conducted over the past year also consistently showed a preference for changing the ticker symbol from "FFIE" to "FFAI." The Company plans to announce the date and detailed plans for the official stock ticker symbol change and “FF AI Open Day” in January 2025. “Since its establishment, AI has been an FF cornerstone,” said Matthias Aydt, Global CEO of Faraday Future. “The stock ticker ‘FFAI’ better reflects the Company’s strategic direction. With FF’s AI technology empowering the FX strategy and the gradual implementation of this strategy, we aim to create AIEVs with extreme price-experience ratio, addressing gaps in the U.S. AIEV market, including AI cabins. Our goal is to drive the comprehensive AI transformation of the U.S. EV industry.” FF’s All-AI Technology Architecture to push the boundaries of AIEV Since its founding, FF has recognized that intelligent electric vehicles are not merely tools for transportation but dynamic, evolving “mobile robots.” FF has always believed that its foundation is in AI technologies. AI is at the core of the FF aiHyper 6x4 Architecture 2.0. By leveraging specialized large AI models in the mobility sector, FF AI aims to achieve complete AI integration through cross-domain computing, algorithms, and data, along with end-to-end full-chain integration. This enables a fully integrated AI-driven technology structure, where the four major AI engines empower the four technology systems and six technology platforms. Magic All-In-One AI Engine is powered by a multi-modal large model driven by visual language models (VLMs), aiming at integrating road pre-scanning, cloud data, and vehicle sensors to deliver the ultimate driving experience. Hyper Multi-Vectoring AI engine could leverage large AI models to enable AI-driven control of steering, braking, and power delivery, aiming to unleash the vehicle's Hyper performance through AI technology. The 3rd aiSpace AI Engine leverages proprietary large-scale models specifically designed for mobility, delivering comprehensive intelligent services by seamlessly integrating end-to-end computation, algorithms, and cross-domain data. FF aiDriving AI Engine utilizes a large VLM to achieve deep integration of vision, language, speech, and historical data to make every journey safe, intelligent, and enjoyable. By integrating data from the mobility ecosystem and incorporating third-party general-purpose large models alongside proprietary large-scale models tailored for mobility, the FF AI platform aims to push the boundaries of AIEV technologies and pave the way for an open, collaborative, and mutually beneficial future mobility ecosystem. The FX strategy presents an excellent opportunity for the application and evolution of the Company’s AI strategy. FF’s AI capabilities are planned to empower the FX brand through iterative innovation, enabling AI to consistently redefine the mobility experience. Comprehensive AI Strategy Could Deliver Multi-Dimensional Value for Users, Partners and Industry FF’s AI strategy includes introducing new revenue streams, such as in-vehicle subscriptions and AI-driven value-added services. These innovations could also enhance user loyalty and recognition. For users, FF and FX products could act as “intelligent partners,” with product design centered on natural interaction methods, including voice and gesture controls. These features would deliver intuitive, seamless interactions that continuously improve through learning, offering personalized AI experiences. Through its “AI-First” approach and co-creation ecosystem, FF is driving the evolution of cars from traditional vehicles to intelligent mobile devices, setting new benchmarks for future smart vehicles. By fostering collaboration with global developers and AI experts, FF aims to propel industry-wide innovation, benefiting the sector and its partners. ABOUT FARADAY FUTURE Faraday Future is the pioneer of the Ultimate AI TechLuxury ultra spire market in the intelligent EV era, and the disruptor of the traditional ultra-luxury car civilization epitomized by Ferrari and Maybach. FF is not just an EV Company, but also a software-driven intelligent internet Company. Ultimately FF aims to become a User Company by offering a shared intelligent mobility ecosystem. FF remains dedicated to advancing electric vehicle technology to meet the evolving needs and preferences of users worldwide, driven by a pursuit of intelligent and AI-driven mobility. FORWARD LOOKING STATEMENTS This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding changing the Company’s ticker symbol, hosting an AI open day event, and full integration of AI in the Company’s vehicles, are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include, among others: the Company may determine to not change its ticker symbol; the Company may determine to not host an AI open day event; the Company’s ability to fully integrate AI into its vehicles on a cost effective basis, if at all; the Company’s ability to secure the necessary funding to execute on the FX strategy, which will be substantial; the Company’s ability to secure additional agreements with OEMs that are necessary to execute on the FX strategy; the Company’s ability to continue as a going concern and improve its liquidity and financial position; the Company’s ability to pay its outstanding obligations; the Company's ability to remediate its material weaknesses in internal control over financial reporting and the risks related to the restatement of previously issued consolidated financial statements; the Company’s limited operating history and the significant barriers to growth it faces; the Company’s history of losses and expectation of continued losses; the success of the Company’s payroll expense reduction plan; the Company’s ability to execute on its plans to develop and market its vehicles and the timing of these development programs; the Company’s estimates of the size of the markets for its vehicles and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company’s vehicles; the Company’s ability to cover future warranty claims; the success of other competing manufacturers; the performance and security of the Company’s vehicles; current and potential litigation involving the Company; the Company’s ability to receive funds from, satisfy the conditions precedent of and close on the various financings described elsewhere by the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company’s indebtedness; the Company’s ability to cover future warranty claims; the Company’s ability to use its “at-the-market” program; insurance coverage; general economic and market conditions impacting demand for the Company’s products; potential negative impacts of a reverse stock split; potential cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; circumstances outside of the Company's control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil unrest; risks related to the Company's operations in China; the success of the Company's remedial measures taken in response to the Special Committee findings; the Company’s dependence on its suppliers and contract manufacturer; the Company's ability to develop and protect its technologies; the Company's ability to protect against cybersecurity risks; and the ability of the Company to attract and retain employees, any adverse developments in existing legal proceedings or the initiation of new legal proceedings, and volatility of the Company’s stock price. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s Form 10-K filed with the SEC on May 28, 2024, as amended on May 30, 2024, and June 24, 2024, as updated by the “Risk Factors” section of the Company’s first quarter 2024 Form 10-Q filed with the SEC on July 30, 2024, and other documents filed by the Company from time to time with the SEC. View source version on businesswire.com : https://www.businesswire.com/news/home/20241125391240/en/ Investors (English):ir@faradayfuture.comInvestors (Chinese):cn-ir@faradayfuture.comMedia:john.schilling@ff.com KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: SOFTWARE VEHICLE TECHNOLOGY MOBILE/WIRELESS EV/ELECTRIC VEHICLES INTERNET DATA MANAGEMENT ALTERNATIVE VEHICLES/FUELS IOT (INTERNET OF THINGS) TECHNOLOGY AUTOMOTIVE ARTIFICIAL INTELLIGENCE AUTOMOTIVE MANUFACTURING MANUFACTURING SOURCE: Faraday Future Intelligent Electric Inc. Copyright Business Wire 2024. PUB: 11/25/2024 05:02 PM/DISC: 11/25/2024 05:01 PM http://www.businesswire.com/news/home/20241125391240/enThe Ducks will ring in December by hosting the Ottawa Senators on Sunday in a matchup of teams that are an eyelash under .500 with designs on gaining some upward momentum. They’ll enter the clash with identical .477 points percentages that situate them near the bottom of their respective divisions but not far behind a crowded pack of middling clubs. The Ducks have had more of a defensive inclination while the Senators have shown more scoring pop to date. Ducks coach Greg Cronin said his team hadn’t “had too many stinkers” of late, and that’s been reflected by their 5-3-1 record across their past nine games, with four of their five-plus-goal games this season arriving in that span. “Since we got back from that New York trip, I think we’ve been on a pretty good path in terms of playing with an identity and competing,” Cronin said. They had to grind hard on Black Friday, when they played what Cronin described as something of a postseason-style game against the Kings at Honda Center. Though they fell 2-1 to what veteran forward Ryan Strome described as a “mature, veteran team” that they couldn’t quite edge past despite playing a “disciplined, structured and north-south” game, the Ducks still felt they carried forward some positive indicators from their recent play. “It was a good hockey game. We competed hard. I thought we dictated a lot of the game. We played similar to the way we’ve been playing,” Strome said. Kings coach Jim Hiller concurred. With teams frequently playing the Southern California franchises back to back, he and Cronin get constant looks at one another’s teams during pre-scouts, and Hiller assessed the Ducks’ performance quite favorably. “I thought – we’ve played them this year, I’ve scouted them this year – I thought that’s the best game they’ve played this year. I thought they played very well,” Hiller said. Time will tell if Sunday’s match elicits similar plaudits from Ottawa coach Travis Green, who spent parts of two seasons with the Ducks as a player and is in his first year as the Sens’ head coach after previously guiding the Vancouver Canucks and New Jersey Devils briefly. Though Brock McGinn has made some progress in his return, he and Robby Fabbri remained unavailable. So, too, did Leo Carlsson, whose upper-body injury has kept him out of the Ducks’ past two matches. Cam Fowler will be a game-time decision. Related Articles Troy Terry has four points across his three-game scoring streak, while Trevor Zegras just snapped a four-gamer that saw him compile six points. For Ottawa, forwards Tim Stützle and Drake Batherson each have seven points in the Sens’ past five outings. Captain Brady Tkachuk, whom Cronin suggested could be a model for his own power forward Mason McTavish, has racked up five points during a three-game surge. Those are the three Senators scoring above a point per game this season, with Stützle’s 28 points in 22 games leading the way. When: 5 p.m. Sunday Where: Honda Center How to watch: Victory+

SilverStone Kublai KL07E Review

November 30, 2024 feature This article has been reviewed according to Science X's editorial process and policies . Editors have highlightedthe following attributes while ensuring the content's credibility: fact-checked peer-reviewed publication trusted source proofread by Ingrid Fadelli , Phys.org Perovskites, materials with a crystal structure that mirrors that of the mineral calcium titanate CaTiO3, exhibit properties that are advantageous for developing various technologies. For instance, they have proved promising for designing photovoltaic (PV) systems and electronic devices. Perovskites are also ideal materials to explore a variety of quantum states, including orbital order, magnetism and superconductivity. Moreover, physicists can carefully engineer these materials to unlock various tunable properties, which typically result from subtle deviations from the cubic perovskite structure. Realizing these deviations and controlling them to attain specific properties can be highly challenging. In a recent paper published in Nature Physics , researchers at the Max Planck Institute for Solid State Research introduced a promising strategy to realize subtle atomic displacements in the vanadate perovskite YVO 3 . "The objective of our recent study was to gain a fundamental understanding of how the functional properties of a crystalline material change when it is grown as a thin film in an oriented manner on different facets of another crystal, while control parameters such as lattice and polarity mismatch with the film remain almost unchanged," Eva Benckiser, senior author of the paper, told Phys.org. To directionally imprint slight atomic displacements in the antiferromagnetic Mott insulator YVO 3 , the researchers deposited epitaxial films on different facets of the same substrate. Notably, they observed that the vanadate films on different facets of the substrate exhibited distinct spin-orbital ordering patterns. "In materials with strong electron-electron correlations, such as the perovskite vanadate YVO 3 , the physical properties are very sensitive to the smallest structural changes, such as those that occur at interfaces when materials with different crystal lattices grow together," explained Benckiser. "In the present work, we used two cuts of an orthorhombic substrate material, YAlO 3 , which have facets that are indistinguishable in the cubic reference system and have a very similar lattice mismatch with YVO 3 ." The recent study by Benckiser and her colleagues demonstrates that substrate facets could be leveraged to carefully tailor the spin-orbital behavior of perovskites. Initial experiments highlight the promise of their proposed approach, which could eventually be used to design new materials for various technologies. "Our light scattering experiments show that the magnetic ordering patterns are different depending on the substrate facet and that this is due to the subtle difference in the atomic displacements imprinted at the substrate-film interface," said Benckiser. "This fundamental effect can be used to stabilize desired phases in various functional perovskite materials, for example, to create novel spintronic materials." The researchers hope their recent work will contribute to the precise engineering of quantum materials, offering physicists an alternative route for manipulating their properties. Meanwhile, they plan to continue building on the approach they devised while also exploring the extent to which imprinted displacement patterns affect the properties of other perovskites. "In the future, we plan to investigate the length scale of the imprinted orthorhombic displacements in more detail and to explore the influence of different facets in other functional perovskite thin films," added Benckiser. More information: Padma Radhakrishnan et al, Imprinted atomic displacements drive spin–orbital order in a vanadate perovskite, Nature Physics (2024). DOI: 10.1038/s41567-024-02686-8 . Journal information: Nature Physics © 2024 Science X NetworkThe Golden Gamble of the Gold Coast is ‘GALAMSEY’Louisiana Tech 85, S. Illinois 79, OT